Matches in Wikidata for { <http://www.wikidata.org/entity/Q37399450> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q37399450 description "article científic" @default.
- Q37399450 description "article scientifique" @default.
- Q37399450 description "articolo scientifico" @default.
- Q37399450 description "artigo científico" @default.
- Q37399450 description "artículu científicu espublizáu en 2009" @default.
- Q37399450 description "bilimsel makale" @default.
- Q37399450 description "scientific article published on August 2009" @default.
- Q37399450 description "vedecký článok" @default.
- Q37399450 description "vetenskaplig artikel" @default.
- Q37399450 description "videnskabelig artikel" @default.
- Q37399450 description "vědecký článek" @default.
- Q37399450 description "wetenschappelijk artikel" @default.
- Q37399450 description "wissenschaftlicher Artikel" @default.
- Q37399450 description "наукова стаття, опублікована в серпні 2009" @default.
- Q37399450 description "научни чланак" @default.
- Q37399450 description "مقالة علمية نشرت في أغسطس 2009" @default.
- Q37399450 name "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 name "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 name "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 type Item @default.
- Q37399450 label "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 label "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 label "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 prefLabel "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 prefLabel "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 prefLabel "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 P1433 Q37399450-551A09B9-E52D-448F-8551-5395C5EC7BA9 @default.
- Q37399450 P1476 Q37399450-E23B2A4E-26E5-46C9-96E1-F6F7F9EBA776 @default.
- Q37399450 P2093 Q37399450-84550559-91FD-4FA0-B957-9901B29D170A @default.
- Q37399450 P2093 Q37399450-B4375D16-2D52-48A5-BB36-AB09C624A34A @default.
- Q37399450 P2860 Q37399450-2928A568-2862-444B-9EC9-60B428B1E4FE @default.
- Q37399450 P2860 Q37399450-9999568F-5E57-4853-AA1E-DD4652FCDE73 @default.
- Q37399450 P2860 Q37399450-9E1AECD5-CCF5-4CA0-8452-FC928108F268 @default.
- Q37399450 P2860 Q37399450-B4A156F7-89A5-4F7B-8114-7D045D1C61DF @default.
- Q37399450 P2860 Q37399450-BA23BB8E-1D44-4527-9031-EA7E2FC38B94 @default.
- Q37399450 P2860 Q37399450-D1B0AEE7-13F8-4CC5-84E0-2534497CBD1C @default.
- Q37399450 P2860 Q37399450-D5A4BD0A-7F2C-4CB0-B1A8-855E6E2FE05F @default.
- Q37399450 P2860 Q37399450-D74C1C46-9EA2-40A0-AD11-8EFCF712DAF0 @default.
- Q37399450 P2860 Q37399450-E63E0E75-4BCE-4F96-A24F-C6C153C56214 @default.
- Q37399450 P2860 Q37399450-E9A92E1E-0CCB-4A2E-9C7B-0A70D57F8E7E @default.
- Q37399450 P2860 Q37399450-EBC01754-7616-4389-85D3-C864AC63FC26 @default.
- Q37399450 P304 Q37399450-7EBA739D-E20B-4D5C-989D-2B132301C2B0 @default.
- Q37399450 P31 Q37399450-8560BDF0-290F-49FB-AF53-1897427F7955 @default.
- Q37399450 P356 Q37399450-EF998469-B567-4806-A930-D09726FAAE8E @default.
- Q37399450 P407 Q37399450-8960CF7D-5BB2-4991-88C7-BE1527787E6A @default.
- Q37399450 P433 Q37399450-24E08506-39B3-4902-8C5D-787C34CC4DC6 @default.
- Q37399450 P478 Q37399450-EE4ABCAB-A218-4FBF-B3EE-1A1A8777E578 @default.
- Q37399450 P50 Q37399450-25820F6F-D4E9-41A8-A827-A4606EEEA224 @default.
- Q37399450 P577 Q37399450-B287BF56-CAD7-40D8-85B2-D7B0F3D7D38E @default.
- Q37399450 P5875 Q37399450-039AE77D-45EA-43DC-9439-332DDC8AE966 @default.
- Q37399450 P698 Q37399450-E6DFE538-7943-4B18-B029-A8737CD52FFA @default.
- Q37399450 P921 Q37399450-75C5DCC2-154A-44B5-A423-928E9E5BEF34 @default.
- Q37399450 P932 Q37399450-FF30CAF7-D637-4734-A37F-0DDBF93A2ECA @default.
- Q37399450 P356 J.1365-2125.2009.03446.X @default.
- Q37399450 P698 19694744 @default.
- Q37399450 P1433 Q176044 @default.
- Q37399450 P1476 "The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine" @default.
- Q37399450 P2093 "Jørgen G Bramness" @default.
- Q37399450 P2093 "Pål Gjerden" @default.
- Q37399450 P2860 Q36512651 @default.
- Q37399450 P2860 Q37161528 @default.
- Q37399450 P2860 Q44336414 @default.
- Q37399450 P2860 Q45141351 @default.
- Q37399450 P2860 Q45214860 @default.
- Q37399450 P2860 Q46355905 @default.
- Q37399450 P2860 Q46608097 @default.
- Q37399450 P2860 Q57305050 @default.
- Q37399450 P2860 Q57809776 @default.
- Q37399450 P2860 Q68089189 @default.
- Q37399450 P2860 Q80185748 @default.
- Q37399450 P304 "238-242" @default.
- Q37399450 P31 Q13442814 @default.
- Q37399450 P356 "10.1111/J.1365-2125.2009.03446.X" @default.
- Q37399450 P407 Q1860 @default.
- Q37399450 P433 "2" @default.
- Q37399450 P478 "68" @default.
- Q37399450 P50 Q64176813 @default.
- Q37399450 P577 "2009-08-01T00:00:00Z" @default.
- Q37399450 P5875 "26755278" @default.
- Q37399450 P698 "19694744" @default.
- Q37399450 P921 Q20 @default.
- Q37399450 P932 "2767288" @default.